GlassScriptPhysician profile
Joseph D Giovinco
NPI 1316941115
$18,038.15
in general payments reported to CMS, 2019-2025
23 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,433 · 2020: $71.36 · 2021: $178 · 2022: $3,946 · 2023: $4,179 · 2024: $2,961 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6,493 · Food and Beverage: $867 · Travel and Lodging: $38.32 · Education: $12.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,492.72 |
| Food and Beverage | $867.14 |
| Travel and Lodging | $38.32 |
| Education | $12.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $10,027.08 | 2022-2025 | Orbitum Staple System |
| Medtronic Vascular, INC. | $6,298.48 | 2019 | |
| Curonix LLC | $211.32 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $178.88 | 2023-2024 | Hawkone, Intellis Adaptivestim, Venaseal |
| Aroa Biosurgery Incorporated | $172.68 | 2022 | |
| Horizon Therapeutics Plc | $169.26 | 2019-2023 | Krystexxa |
| Nevro Corp. | $167.37 | 2022-2023 | Senza |
| Treace Medical Concepts, INC. | $148.67 | 2023-2025 | |
| Djo, LLC | $103.03 | 2024 | Dr Comfort |
| Amgen INC. | $101.60 | 2024 | Krystexxa |
| Polarityte, INC. | $84.78 | 2021 | |
| Nabriva Therapeutics, Plc | $54.69 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $41.97 | 2019 | |
| Hikma Pharmaceuticals USA | $41.28 | 2020-2021 | |
| Nalu Medical, INC. | $40.80 | 2024 | Nalu Neurostimulation System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $38.40 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $28.65 | 2019 | |
| Globus Medical, INC. | $27.39 | 2025 | Senza |
| Lifenet Health | $24.32 | 2024 | Theragenesis Wound Matrix |
| Solventum Corporation | $22.34 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Vertex Pharmaceuticals Incorporated | $21.70 | 2025 | |
| Heron Therapeutics, INC. | $20.77 | 2021 | |
| Bioventus LLC | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Giovinco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.